Company Filing History:
2 out of 5,094 
2 out of 4 
1 out of 870 
Years Active: 2010-2013
Title: Valérie Lorin: Innovator in Coronavirus Research
Introduction
Valérie Lorin is a notable inventor based in Montrouge, France. He has made significant contributions to the field of virology, particularly in the study of coronaviruses. With a total of 2 patents, his work has implications for diagnostics and vaccine development.
Latest Patents
Lorin's latest patents focus on a novel strain of severe acute respiratory syndrome (SARS)-associated coronavirus. This strain was derived from a sample collected in Hanoi, Vietnam, and is referenced under number 031589. The invention includes nucleic acid molecules originating from the genome of the virus, as well as proteins and peptides coded by these nucleic acids. Notably, it emphasizes protein N and its applications as diagnostic reagents and potential vaccine components.
Career Highlights
Throughout his career, Valérie Lorin has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Université Paris 7. His research has been pivotal in advancing our understanding of coronaviruses and their potential applications in public health.
Collaborations
Lorin has collaborated with esteemed colleagues in his field, including Sylvie Van Der Werf and Nicolas Escriou. These partnerships have further enriched his research and contributed to the scientific community's knowledge of viral pathogens.
Conclusion
Valérie Lorin's innovative work in coronavirus research highlights his role as a key inventor in the field. His patents and collaborations reflect a commitment to advancing medical science and public health.